Skip to main content
Georgia Public Broadcasting Logo
  • Watch

    Featured Specials and Programs

    • All Creatures Great and Small
    • Antiques Roadshow
    • PBS News Hour
    • Miss Scarlet & The Duke
    • Finding Your Roots
    • Doc Martin
    All Programs

    GPB Originals

    • Georgia Legends
    • Lawmakers
    • A Fork in the Road
    • View Finders
    • Georgia Outdoors
    • Your Fantastic Mind
    GPB Originals

    Browse by Genre

    • Arts & Music
    • Culture
    • Drama
    • Food
    • History
    • News & Public Affairs
    • TV Schedule
    • GPB Programs
    • PBS Passport
    • TV Highlights this Week
    • PBS KIDS
    • Ways to Watch
    • Newsletters
    • Contact GPB
  • Listen

    Featured Programs

    • The Daily
    • Morning Edition
    • All Things Considered
    • Serendipity
    • John Lemley's City Cafe
    • Fresh Air
    • Here and Now
    • Code Switch/Life Kit
    • Wait Wait... Don't Tell Me!
    All Programs

    Podcasts

    • GA Today
    • Salvation South
    • Battleground: Ballot Box
    • Football Fridays in Georgia
    • Narrative Edge
    • Peach Jam Podcast
    • A Fork in the Road
    • Radio Schedule
    • GPB Classical
    • Radio Programs
    • Podcasts
    • GPB News
    • Find Your Station
    • Ways to Listen
    • Contact GPB
    • Newsletters
  • Learn

    Featured

    • Chemistry Matters
    • Classroom Conversations Podcast
    • GASHA Go! World
    • Georgia Farmcraft®
    • Georgia Classroom
    • Georgia Studies Collection
    • Econ Express
    • Let’s Go Enviro
    • Let's Learn GA!
    • Lights, Camera, Budget!
    • Live Explorations
    • Physics in Motion
    • School Stories
    • Virtual Field Trips
    • VR in the Classroom
    • Writers Contest

    For Kids & Teachers

    • GPB Games
    • PBS KIDS
    • PBS LearningMedia

    • on Twitter
    • on Facebook
    • on Email
  • News

    Featured Programs & Series

    • Lawmakers
    • Lawmakers: Beyond the Dome
    • 1A
    • Battleground: Ballot Box
    • GA Today Podcast
    • Storycorps
    • Narrative Edge

    More GPB News

    • Politics
    • Georgia News
    • Justice
    • Arts & Life
    • Health
    All GPB News
    • Radio Schedule
    • Radio Stations
    • GPB Apps
    • Podcasts
    • Contact GPB News
    • Follow Us on Apple News
    • Newsletters
  • Sports

    GHSA Sports

    • Football
    • Basketball
    • Cheerleading
    • On Demand
    • GPB Sports Blog
    All Sports

    High School Football

    • Scores & Schedule
    • On Demand
    • Teams
    • Rankings
    • Brackets
    • Heads Up Georgia
    Football Home
    • GPB Sports App
    • GPB Sports Blog
    • GPB Sports OnDemand
  • Events

    Browse by Type

    • Community
    • Donor
    • Kids & Family
    • Screenings
    All Events

    Browse by Category

    • Education
    • News
    • Sports
    • Television

    Sign up to receive GPB Event announcements via Email.

    Sign up

    • on Twitter
    • on Facebook
    • on Instagram
  • Kids & Families

    For Kids

    • Video
    • Games

    For Parents & Caregivers

    • Kids & Families Blog
    • Kids & Families Events
    • GPB KIDS - Ways to Watch
  • Support Us

    Support GPB

    • Ways to Give
    • Planned Giving
    • Sustainers
    • GPB Passport
    • Leadership Giving
    • Corporate Sponsorship
    • Vehicle Donations
    • GPB Next
    • Matching Gifts
  • Search
GPB Passport icon GPB Passport icon Passport
GPB donate icon GPB donate icon Donate
Listen Live Listen Live Watch Live Watch Live

GPB Newsletter CTA

Sign Up For Our Newsletter

News Topics

  • Georgia
  • National
  • Politics
  • Lawmakers
  • Elections

Don't Miss

Don't Miss:

  • New Podcast: Robbery, Inc
  • Federal Funding Update
  • Explore GPB Passport

News Articles: covid-19 vaccine

The AstraZeneca/Oxford partnership is one of the vaccine development efforts that is furthest along. The company recently began a Phase 3 trial in the United States that aims to enroll 30,000 volunteers.

Tagged as: 

  • Science

COVID-19 Vaccine Trial Paused Due To Illness In Volunteer

AstraZeneca, which is working with the University of Oxford, hasn't said what the illness is. It will try to determine whether the illness is related to the vaccine, or just a chance event.

September 09, 2020
|
By:
  • Joe Palca
A scientist at work on a COVID-19 vaccine candidate at Bogazici University in Istanbul in August.

Tagged as: 

  • Health

How Can You Tell If A COVID-19 Vaccine Is Working?

Several COVID-19 vaccine candidates are being tested now. But why does it take 30,000 volunteers to know if one is safe and effective? And what does it mean to say a vaccine candidate is working?

September 08, 2020
|
By:
  • Joe Palca
Dr. Walter Orenstein

Tagged as: 

  • Health

Emory Expert: COVID-19 Vaccine Could Be A 'Disaster' If Process Is Rushed

Associate Director of the Emory Vaccine Center Dr. Walter Orenstein says it's more likely to have a safe and effective COVID-19 vaccine early next year than this fall.

September 07, 2020
|
By:
  • Ellen Eldridge
World Health Organization Secretary-General Tedros Adhanom Ghebreyesus has warned against what he describes as "vaccine nationalism."

Tagged as: 

  • World

U.S. Won't Join WHO-Led Coronavirus Vaccine Effort, White House Says

A Trump administration spokesman says Washington will continue to engage the rest of the world in vaccine development but won't be "constrained" by the "corrupt" World Health Organization.

September 02, 2020
|
By:
  • Scott Neuman
Several influenza vaccines have been made in the form of a nasal spray, instead of an injection. The sprays confer two kinds of immunity to the recipient but can be difficult technologically to make.

Tagged as: 

  • Health

What A Nasal Spray Vaccine Against COVID-19 Might Do Even Better Than A Shot

A vaccine against the coronavirus needs to keep people from getting very sick and dying. But preventing the spread of the disease is also important, and vaccines delivered by nasal spray may do that.

August 30, 2020
|
By:
  • Joe Palca
Russian President Vladimir Putin announced the approval of Russia's coronavirus vaccine during a government meeting on Tuesday.

Tagged as: 

  • World

Skepticism Greets Putin's Announcement Of Russian Coronavirus Vaccine

It's the first country to approve a COVID-19 vaccine, but it has not finished Phase III trials to assess safety and effectiveness in the general population.

August 12, 2020
|
By:
  • Scott Neuman
Tony Potts, 69, a retiree from Ormond Beach, Fla., receives his first Moderna COVID-19 vaccine shot Tuesday as part of the company's phase three clinical trial.

Tagged as: 

  • Health

Prices For COVID-19 Vaccines Are Starting To Come Into Focus

Moderna, one of the leading horses in the coronavirus vaccine race, has already made deals at between $32 and $37 a dose for some foreign countries. The U.S. price is expected to be lower.

August 08, 2020
|
By:
  • Sydney Lupkin
World Health Organization Director-General Tedros Adhanom Ghebreyesus says that while some COVID-19 vaccine candidates have progressed to phase three testing, the world must remain reliant on "the basics" of disease control. Tedros is seen here last month in Geneva.

Tagged as: 

  • Global Health

WHO Chief Warns 'There Might Never Be' A Silver Bullet For Coronavirus

Vaccine candidates are in advanced clinical trials, and WHO's director-general expresses hope they will be effective. But until then, he said, the world is reliant on "the basics" of disease control.

August 03, 2020
|
By:
  • Laurel Wamsley
Director of the National Institutes of Health, Dr. Francis Collins, holds a model of the coronavirus. This is the sixth vaccine candidate to join Operation Warp Speed's portfolio, and the largest vaccine deal to date.

Tagged as: 

  • Health

U.S. Reaches $2.1 Billion Deal With Sanofi, GlaxoSmithKline For COVID-19 Vaccine Push

This is the sixth vaccine candidate to join Operation Warp Speed's portfolio, and the largest vaccine deal to date.

July 31, 2020
|
By:
  • Sydney Lupkin
A scientist is pictured working during a visit by Britain's Prince William, Duke of Cambridge (unseen), to Oxford Vaccine Group's laboratory facility at the Churchill Hospital in Oxford, west of London on June 24, 2020, on his visit to learn more about the group's work to establish a viable vaccine against coronavirus COVID-19.

Tagged as: 

  • Science

Vaccine Candidate Delivers Protection In A Single Shot (In Monkeys)

Studies involving COVID-19 vaccine candidates in monkeys show promise of an effective vaccine, but it will take large-scale human trials to know for sure if they work.

July 30, 2020
|
By:
  • Joe Palca
Researchers have been investigating how long antibodies to the coronavirus last in people who have recovered from infections.

Tagged as: 

  • Health

How Long Will Immunity To The Coronavirus Last?

Recent studies have raised fears that immunity to the coronavirus might be fleeting, thus making potential vaccines ineffective. The reality of the science is more complex — and more reassuring.

July 23, 2020
|
By:
  • Richard Harris
Norman Hulme

'It's An Honor' Says Local COVID-19 Vaccine Trial Participant

When Norman Hulme heard Emory was opening its vaccine trial to people age 56 and over, he jumped at the chance. The 65-year-old grew up in New York, in...

July 22, 2020
|
By:
  • Ellen Eldridge
An experimental vaccine candidate being developed by AstraZeneca and Oxford University to protect against COVID-19 triggered an immune response against the coronavirus and appeared to be safe.

Tagged as: 

  • Health

Early Oxford-AstraZeneca Coronavirus Vaccine Data 'Encouraging,' Scientists Say

Testing in more than 1,000 people found the vaccine spurred an immune response and had no severe side effects. Larger trials are underway.

July 21, 2020
|
By:
  • Richard Harris and
  • Sydney Lupkin
a vaccine is given in the shoulder

Tagged as: 

  • Health

First COVID-19 Vaccine Tested in US Shows Promising Results

The first vaccine against COVID-19 tested in the United States is moving into its final phase with promising results.

July 14, 2020
|
By:
  • Ellen Eldridge

Newsletter Signup

Sign Up For Our Newsletters

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News

Footer

Footer First Nav (Main Menu)

  • Watch
  • Listen
  • Learn
  • News
  • Sports
  • Events
  • Kids & Families
  • Support Us
  • Search

Footer Second Nav Menu

  • Help Center
  • About GPB
  • Contact Us
  • Closed Captioning
  • Directions
  • Studio Production
  • Program Submissions

Footer Third Nav Menu

  • Support Us
  • Careers
  • Accessibility
  • FCC Public Files
  • Drawing Rules
  • News Media Request
  • Open Records and Document Retention Policy
  • Privacy Policy

Georgia Public Broadcasting

260 14th St. NW
Atlanta, GA 30318
United States

(404) 685-2400 In Atlanta
(800) 222-4788 Outside Atlanta
ask@gpb.org

Newsletter Signup

Sign Up For Our Newsletters

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News
© Copyright 2025, Georgia Public Broadcasting. All Rights Reserved. Georgia Public Radio® GPTV®